64976 Federal Register / Vol. 65, No. 211 / Tuesday, October 31, 2000 / Notices

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, The

Regents of the University of Michigan.

Date: November 1–3, 2000.

Time: 7:30 pm to 12 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn (North Campus), 3600

Plymouth Road, Ann Arbor, MI 48105.

Contact Person: Mary Bell, PhD, Scientific

Review Administrator, Grants Review

Branch, Division of Extramural Activities,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

8058, Bethesda, MD 20892, 301/496–7878.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: October 17, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–27888 Filed 10–30–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary &

Alternative Medicine; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel, NCCAM Special

Emphasis Panel C–07.

Date: November 14–16, 2000.

Time: 6:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 8120 Wisconsin Avenue, Bethesda,

MD 20814.

Contact Person: John C. Chah, PhD,

Scientific Review Administrator, National

Institutes of Health, NCCAM, Building 31,

Room 5B50, 9000 Rockville Pike, Bethesda,

MD 20892, 301–402–4334, johnc@od.nih.gov.

Dated: October 18, 2000,

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–27882 Filed 10–30–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB 4 J2.

Date: November 17, 2000.

Time: 3 pm to 4 pm.

Agenda: To review and evaluate grant

applications.

Place: 2 Democracy Plaza, 6707 Democracy

Boulevard, 6th Floor, Room #647, Bethesda,

MD 20892–5452 (Telephone Conference

Call).

Contact Person: William E. Elzinga, PhD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Room 647, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892–6600 (301) 594–

8895.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB–7 J3.

Date: November 19–20, 2000.

Time: 7:30 pm to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Regency Hotel, One Bethesda

Metro Center, Bethesda, MD 20814.

Contact Person: Lakshmanan Sankaran,

PhD, Scientific Review Administrator,

Review Branch, DEA, NIDDK, Room 659,

6707 Democracy Boulevard, National

Institutes of Health, Bethesda, MD 20892–

6600 (301) 594–7799.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: October 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–27878 Filed 10–30–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, NIAID.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Institute of Allergy and

Infectious Diseases, including

consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, NIAID.

Date: December 11–13, 2000.

Time: December 11, 2000, 8 am to

adjournment on December 13.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Institutes of Health,

Building 4, Conference Room 433, 10 Center

Drive, Bethesda, MD 20892.

Contact Person: Thomas J. Kindt, PhD,

Director, Division of Intramural Research,

National Inst. of Allergy & Infectious

Diseases, Building 10, Room 4A31, Bethesda,

MD 20892, 301 496–3006, tk9c@nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,